Esperer Biotech Llp - Due diligence report
A 360° intelligence report on Esperer Biotech Llp: trust score, financial health, credit view, compliance, directors, growth and distress si…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Esperer Biotech Llp — 360° Intelligence Report
Generated from MCA filings & public recordsEsperer Biotech Llp is assessed as Low Risk with a Trust Score of 80/100. Esperer Biotech Llp is an active limited liability partnership incorporated in 2020, operating in the Animal Husbandry sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.
Report generated on 09 Oct 2026 from the latest processed filings. Esperer Biotech Llp snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
No processed financialsCredit & Compliance Intelligence
Why the scores are what they are- Financial statements needed for a credit view.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2022 - filings overdue.
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| RENINDAS MELE POYILE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SAJITH KALLU PURAYIL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 80Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- No financials on record - ask for audited statements.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 5 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| NALUKETTUPAYASAM LLP | ABC-7771 | Kozhikode, Kerala |
| Alexa Constance Engineering Solutions Private Limited | U42900KL2024PTC089746 | Kozhikode, Kerala |
| Raghukulam Nidhi Limited | U65100KL2021PLN073093 | Kozhikode, Kerala |
| MEDIA ONE BROADCASTING (INDIA) LLP | AAC-3380 | Kozhikode, Kerala |
| Brookhill Holistic Projects Private Limited | U55101KL2010PTC026439 | Kozhikode, Kerala |
| Athins Engineering Private Limited | U45209KL2021PTC072970 | Kozhikode, Kerala |
| SHANKAI TRADING LLP | AAZ-2953 | Kozhikode, Kerala |
| SOMAN&SONS REALTIES LLP | AAH-6706 | Kozhikode, Kerala |
| Ajal Associates Private Limited | U51909KL2020PTC062686 | Kozhikode, Kerala |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Esperer Biotech Llp before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Esperer Biotech Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Esperer Biotech Llp - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Esperer Biotech Llp pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Esperer Biotech Llp - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Esperer Biotech Llp an active company?
Esperer Biotech Llp has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Esperer Biotech Llp financially healthy?
Processed financial statements are not yet available for Esperer Biotech Llp, so its financial health is unassessed.
Should I do business with Esperer Biotech Llp?
Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Esperer Biotech Llp?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Esperer Biotech Llp have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Esperer Biotech Llp up to date with its ROC filings?
Last balance sheet is for Mar 2022 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Esperer Biotech Llp?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.